デフォルト表紙
市場調査レポート
商品コード
1442871

ゲノム編集の世界市場:業界分析、規模、シェア、成長、動向、予測(2023年~2031年)

Genome Editing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 140 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ゲノム編集の世界市場:業界分析、規模、シェア、成長、動向、予測(2023年~2031年)
出版日: 2024年01月31日
発行: Transparency Market Research
ページ情報: 英文 140 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゲノム編集市場- レポートの範囲

世界のゲノム編集市場に関する当レポートは、過去と現在の成長動向、および2023年~2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界のゲノム編集市場の収益を提供します。 2017年~2031年の期間、2023年を基準年、2031年を予測年とみなします。このレポートは、2023年~2031年までの世界のゲノム編集市場の複合年間成長率(CAGR %)も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、ゲノム編集市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界のゲノム編集市場の競合情勢を詳しく掘り下げています。世界のゲノム編集市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のゲノム編集市場企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測(2017年~2031年)

第5章 重要な洞察

  • 規制シナリオ
  • 技術の進歩
  • COVID-19パンデミックが業界に与える影響

第6章 世界市場の分析と予測:技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:技術別(2017年~2031年)
    • CRISPR
    • TALEN
    • ZFN
    • その他
  • 市場魅力度:技術別

第7章 世界市場の分析と予測:用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:用途別(2017年~2031年)
    • 細胞株の編集
    • 動物
    • 植物
    • その他
  • 市場魅力度:用途別

第8章 世界市場の分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:エンドユーザー別(2017年~2031年)
    • 製薬会社とバイオテクノロジー企業
    • 学術機関および政府研究機関
    • 臨床研究機関
  • 市場魅力度:エンドユーザー別

第9章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度:国・地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東およびアフリカ市場の分析と予測

第15章 競合情勢

  • 市場企業 - 競合マトリックス(企業の階層および規模別)
  • 市場シェア分析:企業別(2022年)
  • 企業プロファイル
    • Merck KGaA
    • AstraZeneca
    • Takara Bio Inc.
    • Cellectis SA
    • CRISPR Therapeutics
    • Cibus Inc.
    • RECOMBINETICS
    • Sangamo Therapeutics
    • Thermo Fisher Scientific, Inc.
図表

List of Tables

  • Table 01: Global Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 02: Global Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Genome Editing Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Genome Editing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 07: North America Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 11: Europe Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 15: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 19: Latin America Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 23: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Genome Editing Market Size, by Technology, 2022
  • Figure 02: Global Genome Editing Market Share (%), by Technology, 2022
  • Figure 03: Global Genome Editing Market Size, by Application, 2022
  • Figure 04: Global Genome Editing Market Share (%), by Application, 2022
  • Figure 05: Global Genome Editing Market Size, by End-user, 2022
  • Figure 06: Global Genome Editing Market Share (%), by End-user, 2022
  • Figure 07: Global Genome Editing Market, by Region (2022-2031)
  • Figure 08: Global Genome Editing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 09: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031
  • Figure 10: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022
  • Figure 11: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2031
  • Figure 12: Global Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 13: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 14: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022
  • Figure 15: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2031
  • Figure 16: Global Genome Editing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 17: Global Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
  • Figure 18: Global Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022
  • Figure 19: Global Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2031
  • Figure 20: Global Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 21: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Region, 2022-2031
  • Figure 22: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Region, 2022
  • Figure 23: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Region, 2031
  • Figure 24: Global Genome Editing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 25: North America Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 26: North America Genome Editing Market Value Share Analysis, by Country, 2022-2031
  • Figure 27: North America Genome Editing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031
  • Figure 29: North America Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 30: North America Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 31: North America Genome Editing Market Attractiveness Analysis, by Application, 2023-31
  • Figure 32: North America Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
  • Figure 33: North America Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Europe Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 35: Europe Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Europe Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Europe Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031
  • Figure 38: Europe Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 39: Europe Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 40: Europe Genome Editing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 41: Europe Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
  • Figure 42: Europe Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 43: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44: Asia Pacific Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 45: Asia Pacific Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031
  • Figure 47: Asia Pacific Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 48: Asia Pacific Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 49: Asia Pacific Genome Editing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 50: Asia Pacific Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
  • Figure 51: Asia Pacific Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Latin America Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 53: Latin America Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 54: Latin America Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Latin America Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031
  • Figure 56: Latin America Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 57: Latin America Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 58: Latin America Genome Editing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 59: Latin America Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
  • Figure 60: Latin America Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 61: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 62: Middle East & Africa Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 63: Middle East & Africa Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 64: Middle East & Africa Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031
  • Figure 65: Middle East & Africa Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 66: Middle East & Africa Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 67: Middle East & Africa Genome Editing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 68: Middle East & Africa Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
  • Figure 69: Middle East & Africa Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL46494

Genome Editing Market - Scope of Report

TMR's report on the global genome editing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global genome editing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global genome editing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the genome editing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global genome editing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global genome editing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global genome editing market.

The report delves into the competitive landscape of the global genome editing market. Key players operating in the global genome editing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global genome editing market profiled in this report.

Key Questions Answered in Global genome editing market Report:

  • What is the sales/revenue generated by wearable injectors across all regions during the forecast period?
  • What are the opportunities in the global genome editing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Genome Editing Market - Research Objectives and Research Approach

The comprehensive report on the global genome editing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global genome editing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global genome editing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Genome Editing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Genome Editing Market Analysis and Forecasts, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario
  • 5.2. Technological Advancements
  • 5.3. Covid-19 Pandemic Impact on Industry

6. Global Genome Editing Market Analysis and Forecasts, By Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Technology, 2017-2031
    • 6.3.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
    • 6.3.2. Transcription activator-like effector nuclease (TALEN)
    • 6.3.3. Zinc finger nuclease (ZFN)
    • 6.3.4. Other technologies
  • 6.4. Market Attractiveness By Technology

7. Global Genome Editing Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2017-2031
    • 7.3.1. Cell Line Editing
    • 7.3.2. Animal Genome Editing
    • 7.3.3. Plant Genome Editing
    • 7.3.4. Others
  • 7.4. Market Attractiveness By Application

8. Global Genome Editing Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2017-2031
    • 8.3.1. Pharmaceutical Companies and Biotechnology Companies
    • 8.3.2. Academics and Government Research Institutes
    • 8.3.3. Clinical Research Organizations
  • 8.4. Market Attractiveness By End-user

9. Global Genome Editing Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Genome Editing Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Technology, 2017-2031
    • 10.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
    • 10.2.2. Transcription activator-like effector nuclease (TALEN)
    • 10.2.3. Zinc finger nuclease (ZFN)
    • 10.2.4. Other technologies
  • 10.3. Market Value Forecast By Application, 2017-2031
    • 10.3.1. Cell Line Editing
    • 10.3.2. Animal Genome Editing
    • 10.3.3. Plant Genome Editing
    • 10.3.4. Others
  • 10.4. Market Value Forecast By End-user, 2017-2031
    • 10.4.1. Pharmaceutical Companies and Biotechnology Companies
    • 10.4.2. Academics and Government Research Institutes
    • 10.4.3. Clinical Research Organizations
  • 10.5. Market Value Forecast By Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Technology
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Genome Editing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Technology, 2017-2031
    • 11.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
    • 11.2.2. Transcription activator-like effector nuclease (TALEN)
    • 11.2.3. Zinc finger nuclease (ZFN)
    • 11.2.4. Other technologies
  • 11.3. Market Value Forecast By Application, 2017-2031
    • 11.3.1. Cell Line Editing
    • 11.3.2. Animal Genome Editing
    • 11.3.3. Plant Genome Editing
    • 11.3.4. Others
  • 11.4. Market Value Forecast By End-user, 2017-2031
    • 11.4.1. Pharmaceutical Companies and Biotechnology Companies
    • 11.4.2. Academics and Government Research Institutes
    • 11.4.3. Clinical Research Organizations
  • 11.5. Market Value Forecast By Country, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Technology
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Asia Pacific Genome Editing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Technology, 2017-2031
    • 12.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
    • 12.2.2. Transcription activator-like effector nuclease (TALEN)
    • 12.2.3. Zinc finger nuclease (ZFN)
    • 12.2.4. Other technologies
  • 12.3. Market Value Forecast By Application, 2017-2031
    • 12.3.1. Cell Line Editing
    • 12.3.2. Animal Genome Editing
    • 12.3.3. Plant Genome Editing
    • 12.3.4. Others
  • 12.4. Market Value Forecast By End-user, 2017-2031
    • 12.4.1. Pharmaceutical Companies and Biotechnology Companies
    • 12.4.2. Academics and Government Research Institutes
    • 12.4.3. Clinical Research Organizations
  • 12.5. Market Value Forecast By Country, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Technology
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country

13. Latin America Genome Editing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Technology, 2017-2031
    • 13.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
    • 13.2.2. Transcription activator-like effector nuclease (TALEN)
    • 13.2.3. Zinc finger nuclease (ZFN)
    • 13.2.4. Other technologies
  • 13.3. Market Value Forecast By Application, 2017-2031
    • 13.3.1. Cell Line Editing
    • 13.3.2. Animal Genome Editing
    • 13.3.3. Plant Genome Editing
    • 13.3.4. Others
  • 13.4. Market Value Forecast By End-user, 2017-2031
    • 13.4.1. Pharmaceutical Companies and Biotechnology Companies
    • 13.4.2. Academics and Government Research Institutes
    • 13.4.3. Clinical Research Organizations
  • 13.5. Market Value Forecast By Country, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Technology
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country

14. Middle East & Africa Genome Editing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Technology, 2017-2031
    • 14.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
    • 14.2.2. Transcription activator-like effector nuclease (TALEN)
    • 14.2.3. Zinc finger nuclease (ZFN)
    • 14.2.4. Other technologies
  • 14.3. Market Value Forecast By Application, 2017-2031
    • 14.3.1. Cell Line Editing
    • 14.3.2. Animal Genome Editing
    • 14.3.3. Plant Genome Editing
    • 14.3.4. Others
  • 14.4. Market Value Forecast By End-user, 2017-2031
    • 14.4.1. Pharmaceutical Companies and Biotechnology Companies
    • 14.4.2. Academics and Government Research Institutes
    • 14.4.3. Clinical Research Organizations
  • 14.5. Market Value Forecast By Country, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Technology
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Merck KGaA
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. AstraZeneca
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Takara Bio Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Cellectis SA
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. CRISPR Therapeutics
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Cibus Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. RECOMBINETICS
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Sangamo Therapeutics
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Thermo Fisher Scientific, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview